Compare, Analyse Dishman Pharma with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DISHMAN PHARMA vs ADCOCK INGRAM (S. Africa) - Comparison Results

DISHMAN PHARMA     Change

Dishman Pharmaceuticals is involved in the manufacture of APIs (active pharmaceutical ingredients), intermediates, quaternary compounds and fine chemicals. Besides this, the company is a significant player in the CRAMS (Contract Research and Manufact... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 DISHMAN PHARMA   ADCOCK INGRAM
EQUITY SHARE DATA
    DISHMAN PHARMA
Mar-16
ADCOCK INGRAM
Jun-14
DISHMAN PHARMA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs374344-   
Low Rs129248-   
Sales per share (Unadj.) Rs197.8102.4-  
Earnings per share (Unadj.) Rs21.2-25.8-  
Cash flow per share (Unadj.) Rs34.7-21.4-  
Dividends per share (Unadj.) Rs2.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs179.980.4-  
Shares outstanding (eoy) m80.69168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.32.9 44.0%   
Avg P/E ratio x11.9-11.5 -103.3%  
P/CF ratio (eoy) x7.2-13.9 -52.3%  
Price / Book Value ratio x1.43.7 37.9%  
Dividend payout %9.40-   
Avg Mkt Cap Rs m20,30650,026 40.6%   
No. of employees `0000.84.3 19.3%   
Total wages/salary Rs m5,3553,140 170.6%   
Avg. sales/employee Rs Th19,252.74,027.5 478.0%   
Avg. wages/employee Rs Th6,459.5731.4 883.2%   
Avg. net profit/employee Rs Th2,064.1-1,014.8 -203.4%   
INCOME DATA
Net Sales Rs m15,96117,290 92.3%  
Other income Rs m265121 219.2%   
Total revenues Rs m16,22617,411 93.2%   
Gross profit Rs m4,103-2,996 -136.9%  
Depreciation Rs m1,091746 146.1%   
Interest Rs m944468 201.6%   
Profit before tax Rs m2,334-4,090 -57.1%   
Minority Interest Rs m0-11 0.0%   
Prior Period Items Rs m10-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m624256 244.0%   
Profit after tax Rs m1,711-4,357 -39.3%  
Gross profit margin %25.7-17.3 -148.4%  
Effective tax rate %26.7-6.2 -427.7%   
Net profit margin %10.7-25.2 -42.5%  
BALANCE SHEET DATA
Current assets Rs m11,01812,664 87.0%   
Current liabilities Rs m9,5177,125 133.6%   
Net working cap to sales %9.432.0 29.4%  
Current ratio x1.21.8 65.1%  
Inventory Days Days110111 99.6%  
Debtors Days Days35124 28.1%  
Net fixed assets Rs m16,3047,382 220.9%   
Share capital Rs m16180 201.1%   
"Free" reserves Rs m12,9070-   
Net worth Rs m14,51613,571 107.0%   
Long term debt Rs m4,1894,769 87.8%   
Total assets Rs m29,80525,636 116.3%  
Interest coverage x3.5-7.7 -44.9%   
Debt to equity ratio x0.30.4 82.1%  
Sales to assets ratio x0.50.7 79.4%   
Return on assets %8.9-15.2 -58.7%  
Return on equity %11.8-32.1 -36.7%  
Return on capital %17.5-19.8 -88.5%  
Exports to sales %24.80-   
Imports to sales %3.70-   
Net fx Rs m4,2550-   
CASH FLOW
From Operations Rs m2,7861,476 188.8%  
From Investments Rs m-1,529-453 337.4%  
From Financial Activity Rs m-9414,328 -21.7%  
Net Cashflow Rs m3165,351 5.9%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.75 Rs / ZAR

Compare DISHMAN PHARMA With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare DISHMAN PHARMA With: ABBOTT INDIA  FDC  AUROBINDO PHARMA  NEULAND LABS  SHASUN PHARMA  



Today's Market

Sensex Ends 441 Points Lower; Nifty Settles Below 15,000-Mark(Closing)

Indian share markets witnessed huge selling during closing hours today and ended their day lower.

Related Views On News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps (Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market (Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

The Hidden Tesla in My Great Indian Wealth Project (Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...

How Much Money For Day Trading? (Fast Profits Daily)

Feb 22, 2021

In this video, I'll show you how to allocate your capital as a day trader.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

DISHMAN PHARMA SHARE PRICE


May 29, 2017 (Close)

TRACK DISHMAN PHARMA

  • Track your investment in DISHMAN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DISHMAN PHARMA

DISHMAN PHARMA 8-QTR ANALYSIS

COMPARE DISHMAN PHARMA WITH

FEATURED VIDEOS

The Best Stocks in a Volatile Market

Nifty is Weak but Smallcaps Can Outperform

Gold 65,000 and Silver 84,000 in 2022

How Long Before a Big Stock Market Crash

More Featured Videos

MARKET STATS